14 November 2006 (PharmiWeb)

Resources | Features | Pfizer: still biggest player in hig... The success of neuropathic pain drug Neurontin earned Pfizer its reputation as the "neuropathic pain company" and the US pharmaceutical giant faced very little competition in a relatively untapped market for ten years.

[News Source]